Multicare Institute for research and Innovation

Tacoma, Washington 98405-4048

1 studies enrolling now · 41 studies all time

What they study most

3rd Degree Heart Block, AV Block, AV Block Complete, Abdominal Pain, Acute Coronary Syndrome, Adult Solid Tumor, Angelman Syndrome, Atrial Fibrillation (Permanent), Breast Cancer, Cancer Therapy-Related Diarrhea, Carcinoma, Pancreatic Ductal, Carotid Artery Stenosis

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) — Completed
• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease — Running, not enrolling
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Completed
• A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. — Completed
• Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies — Stopped early
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome — Completed
• An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome — Completed
• Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study — Stopped early
• Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM — Completed
• Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy — Completed
• A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients — Stopped early
• Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy — Completed
• Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) — Completed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC — Status unconfirmed
• Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease — Stopped early
• EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation — Completed
• Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies — Stopped early
• Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis — Status unconfirmed
• Accelerometer Sensing for Micra AV Study — Completed
• VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease — Completed
• A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC — Status unconfirmed
• informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
• Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) — Completed
• Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome — Stopped early
• Junctional AV Ablation in CRT-D: JAVA-CRT — Completed
• Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain — Completed
• Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer — Completed
• The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis — Completed
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• Growth and Tolerance of Young Infants Fed Infant Formula — Completed
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation — Stopped early
• Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty — Completed
• The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus — Completed
• A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis — Completed
• A Study to Monitor the Use of an Amino Acid-Based Infant Formula — Completed
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis — Completed
• Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy — Completed
• A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency — Completed
• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) — Completed